Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 14Nausea 13Ovarian Neoplasms 4Neoplasms 4Lymphoma 4Leukemia, Myeloid, Acute 4Breast Neoplasms 4Sezary Syndrome 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Testicular Neoplasms 2Primary Myelofibrosis 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pdgfra-Associated Chronic Eosinophilic Leukemia 2Neuroblastoma 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Neutrophilic, Chronic 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2

Interventions

pralsetinib 2pembrolizumab 2Brentuximab Vedotin 2Bevacizumab 2ribociclib 1fosaprepitant 1Sunitinib 1Sirolimus 1Radiotherapy, Image-Guided 1Plicamycin 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Genistein 1Gemcitabine 1Erlotinib Hydrochloride 1Dexamethasone 1Cisplatin 1Carboplatin 1Aprepitant 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms, Germ Cell and Embryonal × Aprepitant × Clear all
NCT00572572 2016-04-06

Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors

Hoosier Cancer Research Network

Phase 3 Completed
69 enrolled 14 charts

Neoplasms, Germ Cell and Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡